Endocrine manifestations of hepatitis C virus infection

Nature Clinical Practice Endocrinology and Metabolism

Volumn 5, Issue 1, 2009, Pages 26-34

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^d   Colaci, Michele ^b   Sansonno, Domenico ^c   Fallahi, Poupak ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d University of Pisa School of Medicine ^*

Author keywords

Diabetes mellitus; Hepatitis C virus; Mixed cryoglobulinemia; Thyroid autoimmunity; Thyroid cancer

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; TUMOR NECROSIS FACTOR;

ANTIVIRAL THERAPY; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; CRYOGLOBULINEMIA; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOCRINE DISEASE; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW; TH1 CELL; THYROID CANCER; VIRUS CARCINOGENESIS;

DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM; HEPACIVIRUS; HUMANS; THYROID DISEASES; THYROID NEOPLASMS;

EID: 57649165863     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet1027     Document Type: Review

References (62)

1. Ferri C et al. (2007) B-cells and mixed cryoglobulinemia. Autoimmun Rev 7: 114-120
2. Sansonno D et al. (2007) Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46: 572-578
3. Antonelli A et al. (2008) HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 26 (Suppl 48): S39-S47
4. Antonelli A et al. (2008) Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev [doi:10.1016/j.autrev.2008.07.017]
5. Pateron D et al. (1992) Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 16: 244-245
6. Antonelli A et al. (2006) Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16: 563-572
7. Antonelli A et al. (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117: 10-13
8. Antonelli A et al. (2004) Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 97: 499-506
9. Pazienza V et al. (2007) The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 45: 1164-1171
10. Rodríguez-Torres M et al. (2008) Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol 7: 72-77
11. Giordano TP et al. (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297: 2010-2017
12. Prummel MF and Laurberg P (2003) Interferon-α and autoimmune thyroid disease. Thyroid 13: 547-551
13. Patzwahl R et al. (2001) Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 75: 1332-1338
14. Mihm S et al. (2003) Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-γ and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol 70: 562-570
15. Matskevich AA and Strayer DS (2003) Exploiting hepatitis C virus activation of NFκB to deliver HCV-responsive expression of interferons α and γ. Gene Ther 10: 1861-1873
16. Murata M et al. (2002) Increased frequency of IFN-γ- producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 67: 162-170
17. Itoh Y et al. (2001) Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat 8: 341-348
18. Shields PL et al. (1999) Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163: 6236-6243
19. Butera D et al. (2005) Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106: 1175-1182
20. Diago M et al. (2006) Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55: 374-379
21. Apolinario A et al. (2005) Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 12: 27-37
22. Caturegli P et al. (2000) Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid. Proc Natl Acad Sci USA 97: 1719-1724
23. + lymphocytes. J Clin Endocrinol Metab 86: 5008-5016
24. Antonelli A et al. (2004) High levels of circulating CX chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89: 5496-5499
25. Antonelli A et al. (2005) Increase of interferon-γ inducible α chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152: 171-177
26. Antonelli A et al. (2006) Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 91: 614-620
27. Gowans EJ (2000) Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 20: 85-102
28. Bartolomé J (2008) Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 80: 1588-1594
29. Antonelli A et al. (2008) High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 42: 137-143
30. Antonelli A et al. (2008) Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism 57: 1270-1277
31. Antonelli A et al. (1999) Thyroid cancer in patients with hepatitis C infection. JAMA 281: 1588
32. Antonelli A et al. (2002) Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 20: 693-696
33. Montella M et al. (2001) HCV and cancer: a case-control study in a high-endemic area. Liver 21: 335-341
34. Montella M et al. (2003) Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep 10: 133-136
35. Antonelli A et al. (2005) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28: 2548-2550
36. Duberg AS et al. (2005) Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 41: 652-659
37. Antonelli A et al. (2007) Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 17: 447-451
38. Ferri C et al. (1997) Hepatitis-C-virus infection and cancer. Int J Cancer 71: 1113-1115
39. Ferri C et al. (2000) Hepatitis C virus, B-cell disorders, and non-Hodgkin's Lymphoma. In Infectious Causes of Cancer: Targets for Intervention 349-368 (Ed Goedert JJ) Totowa: Humana Press
40. Mori Y et al. (2008) Hepatitis C virus core protein: its coordinate roles with PA28γ in metabolic abnormality and carcinogenicity in the liver. Int J Biochem Cell Biol 40: 1437-1442
41. Okayasu I et al. (1995) Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma: a study of surgical cases among Japanese, and white and African Americans. Cancer 76: 2312-2318
42. Noto H and Raskin P (2006) Hepatitis C infection and diabetes. J Diabetes Complications 20: 113-120
43. Antonelli A et al. (2004) Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 43: 238-240
44. Mehta SH et al. (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133: 592-599
45. Mehta SH et al. (2003) Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38: 50-56
46. Tanaka H et al. (1997) Changes in glucose tolerance after interferon-α therapy in patients with chronic hepatitis C. J Med 28: 335-346
47. Giordanino C et al. (2008) Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol [doi:10.1111/j.1572-0241.2008.02002.x]
48. Aytaman A and McFarlane SI (2008) Uncovering glucose abnormalities in people with hepatitis C infection: should oral glucose tolerance test become a standard of care? Am J Gastroenterol 103: 1941-1943
49. El-Zayadi AR (2008) Hepatic steatosis: a benign disease or a silent killer. World J Gastroenterol 14: 4120-4126
50. Cammà C et al. (2006) Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43: 64-71
51. Adinolfi LE et al. (2001) Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358-1364
52. Rubbia-Brandt L et al. (2000) Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33: 106-115
53. Moriya K et al. (1997) Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78: 1527-1531
54. Knobler H and Schattner A (2005) TNF-α, chronic hepatitis C and diabetes: a novel triad. QJM 98: 1-6
55. Shintani Y et al. (2004) Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126: 840-848
56. Hussain MJ et al. (1994) Hepatic expression of tumor necrosis factor-α in chronic hepatitis B virus infection. J Clin Pathol 47: 1112-1115
57. Masini M et al. (2005) Hepatitis C virus infection and human pancreatic β-cell dysfunction. Diabetes Care 28: 940-941
58. Gale EA (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48: 2195-2199
59. Skowronski M et al. (2006) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 29: 750
60. Antonelli A et al. (2002) Autoimmunity to CD38 and GAD in type I and type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 45: 1298-1306
61. Antonelli A et al. (2006) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 29: 751
62. Christen U and Von Herrath MG (2004) IP-10 and type 1 diabetes: a question of time and location. Autoimmunity 37: 273-282